Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Abbott Laboratories
Ownership Structure: publicly traded (ticker symbol ABT)
Headquartered in: Illinois
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Subsidy Summary | Subsidy Value | Number of Awards |
State/Local | $26,285,972 | 49 |
Federal (grants and allocated tax credits) | $0 | 0 |
TOTAL | $26,285,972 | 49 |
Loan / Bailout Summary | Total Face Value | Number of Awards |
State/Local loans, bond financing and venture capital | $3,000,000 | 2 |
Federal loans, loan guarantees and bailout assistance (not including repayments) | $3,030,000 | 5 |
TOTAL | $6,030,000 | 7 |
Time Period for State and Local Awards: Earliest year of data: 1994. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
Ohio | $10,345,456 | 7 |
California | $5,403,252 | 10 |
Missouri | $3,220,080 | 1 |
Arizona | $2,295,647 | 3 |
Illinois | $1,655,098 | 4 |
All other | $3,366,439 | 24 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
VISX INCORPORATED | California | state | 2006 | $59,748 | | training reimbursement |
ABBOTT DIABETES CARE | California | state | 2007 | $359,454 | | training reimbursement |
ABBOTT DIABETES CARE | California | state | 2010 | $843,336 | | training reimbursement |
ABBOTT VASCULAR, INC. | California | state | 2010 | $1,470,600 | | training reimbursement |
VISX, Inc | California | state | 2004 | undisclosed | | training reimbursement |
Advanced Neuromodulation Systems, Inc. | Oregon | state | 2006 | $29,872 | | training reimbursement |
ABBOTT VASCULAR, INC. | California | state | 2012 | undisclosed | | training reimbursement |
ABBOTT VASCULAR, INC. | California | state | 2012 | $249,570 | | training reimbursement |
Abbott Laboratories, Ross Products Div | Arizona | state | 2004 | $235,647 | | training reimbursement |
ST. JUDE MEDICAL | South Carolina | state | 2009 | $59,305 | | training reimbursement |
ABBOTT MEDICAL OPTICS INC. | California | state | 2013 | $73,582 | | training reimbursement |
ABBOTT VASCULAR, INC. | California | state | 2014 | $344,534 | | training reimbursement |
Abbott Vascular Inc | California | state | 2016 | $1,201,228 | | training reimbursement |
Abbott Laboratories | Arizona | state | 2016 | $240,000 | | training reimbursement |
Abbott Laboratories Retrain | Virginia | state | 2017 | $65,639 | | training reimbursement |
Abbott Laboratories. | Virginia | state | 2017 | $34,078 | | training reimbursement |
Abbott Vascular Inc | California | state | 2021 | $603,200 | | training reimbursement |
Abbott Vascular Inc | California | state | 2022 | $198,000 | | training reimbursement |
Abbott Laboratories | Illinois | state | 2004 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Illinois | state | 2005 | $378,187 | | tax credit/rebate |
Abbott Laboratories | Illinois | state | 2006 | $381,909 | | tax credit/rebate |
Abbott Laboratories | Illinois | state | 2007 | $409,371 | | tax credit/rebate |
Abbott Laboratories | Illinois | state | 2008 | $485,631 | | tax credit/rebate |
Abbott Point of Care | New Jersey | state | 2009 | $246,400 | | tax credit/rebate |
Pacesetter, Inc. (St. Jude Medical) | South Carolina | state | 2009 | undisclosed | | tax credit/rebate |
St. Jude Medical | South Carolina | state | 2006 | undisclosed | | tax credit/rebate |
Lightlab Imaging, Inc | Massachusetts | state | 2011 | $75,148 | | tax credit/rebate |
Advanced Neuromodulation Systems | Texas | local | 2006 | undisclosed | | tax credit/rebate |
Abbott Bioresearch Center, inc. | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
AXIS SHIELD DIAGNOSTICS LIMITED | Washington | state | 2011 | $4,930 | | tax credit/rebate |
Abbott Laboratories | Ohio | state | 2012 | $5,369,069 | | tax credit/rebate |
LightLab Imaging, Inc | Massachusetts | state | 2012 | $121,636 | | tax credit/rebate |
LightLab Imaging, Inc | Massachusetts | state | 2012 | $515,000 | | tax credit/rebate |
Abbott Laboratories, Ross Products Division | Ohio | state | 2006 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Ohio | local | 2019 | $2,530,230 | | tax credit/rebate |
St. Jude Medical Cardiology Division, Inc. | South Carolina | state | 2018 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Arizona | state | 2018 | $1,820,000 | | tax credit/rebate |
Alere, Inc | Missouri | state | 2017 | $3,220,080 | | tax credit/rebate |
St. Jude Medical | Minnesota | state | 2022 | undisclosed | | sales tax exemption |
ABBOTT LABORATORIES, INC. | Michigan | local | 1994 | undisclosed | | property tax abatement |
KNOLL PHARMACEUTICAL COMPANY | Michigan | local | 1996 | undisclosed | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2011 | $16,437 | | property tax abatement |
ABBOTT NUTRITION ABBOTT LABORATORIES | Michigan | local | 2007 | undisclosed | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2012 | $15,630 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2013 | $18,018 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2014 | $13,652 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2015 | $6,697 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2016 | $8,387 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Maine | state | 2017 | $7,824 | | property tax abatement |
ABBOTT DIAGNOSTICS SCARBOROUGH INC | Maine | state | 2018 | $7,368 | | property tax abatement |
ABBOTT DIAGNOSTICS SCARBOROUGH INC | Maine | state | 2019 | $7,368 | | property tax abatement |
Abbott Laboratories, Ross Products | Michigan | state | 2011 | undisclosed | | property tax abatement |
Abbott Diagnostics Scarborough Inc | Maine | state | 2021 | $4,806 | | property tax abatement |
ABBOTT LABORATORIES | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
ABBOTT LABORATORIES | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
Abbott Point of Care Inc. and Abbott Diabetes Care | New Jersey | state | 2008 | $1,218,244 | | grant |
ABBOTT LABORATORIES | Ohio | state | 2012 | $695,000 | | grant |
ABBOTT LABORATORIES | Ohio | state | 2008 | $47,957 | | grant |
ABBOTT LABORATORIES | Ohio | state | 2012 | $300,000 | | grant |
ABBOTT LABORATORIES | Ohio | state | 2012 | $1,380,000 | | grant |
ABBOTT LABORATORIES | Ohio | state | 2014 | $23,200 | | grant |
Abbott Laboratories | North Carolina | state | 2003 | $50,000 | | grant |
Abbott Laboratories | Virginia | state | 2016 | $240,000 | | grant |
Abbott Laboratories | Virginia | state | 2016 | $300,000 | | grant |
Abbott Laboratories | Virginia | state | 2020 | $300,000 | | grant |
Biosite Incorporated | United States | federal | 2007 | | $360,000 | federal loan or loan guarantee |
Biosite Incorporated | United States | federal | 2007 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | United States | federal | 2008 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | United States | federal | 2007 | | $270,000 | federal loan or loan guarantee |
Cholestech Corporation | United States | federal | 2007 | | $1,500,000 | federal loan or loan guarantee |
Abbott Laboratories | Ohio | state | 2019 | undisclosed | | enterprise zone |
Abbott Laboratories | Texas | state | 2020 | undisclosed | | enterprise zone |